Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587370 | SCV000697075 | uncertain significance | not provided | 2017-01-20 | criteria provided, single submitter | clinical testing | Variant summary: The HBB c.125T>C (p.Phe42Ser also known as Hb Denver) variant causes a missense change involving the alteration of a conserved nucleotide, which 3/3 in silico tools (SNPs&GO and MutationTaster not captured due to low reliability index) predict a damaging outcome, although these predictions have yet to be functionally assessed. The variant of interest was not observed in controls (ExAC, 1000 Gs, or ESP). A publication cites the variant in a family that presented as asymptomatic with reduced O2 affinity, cyanosis and mild anemia. OMIM cites the variant without a classification. Therefore, until additional information becomes available, the variant of interest has been classified as a "Variant of Uncertain Signficance." |
OMIM | RCV000016795 | SCV000037065 | other | HEMOGLOBIN DENVER | 2017-12-12 | no assertion criteria provided | literature only |